首页> 外国专利> method of orally administered, blood sugar lowering bentseenisulfonyylivirtsa substances to prepare.

method of orally administered, blood sugar lowering bentseenisulfonyylivirtsa substances to prepare.

机译:口服的方法,应准备降血糖的苯氏磺酰肌醇物质。

摘要

1,153,272. Benzenesulphonyl ureas. FARBWERKE HOECHST A.G. 25 July, 1966 [27 July, 1965], No. 33285/66. Heading C2C. Novel compounds of the formula (wherein R is C 1-4 alkyl or C 2-4 alkenyl; X is halogen, C 1-4 alkyl or C 1-4 alkoxy; and RSP1/SP is cyclohexyl, methyl- or ethyl-cyclohexyl or endomethylene - (cyclohexyl or cyclohexenyl)- methyl) and salts thereof are prepared (1) by the action of amines NH 2 RSP1/SP on the appropriately substituted benzenesulphonyl isocyanates, benzenesulphonyl carbamic or thiocarbamic acid esters, benzenesulphonyl carbamic acid halides or benzenesulphonyl ureas; or (2) by the action of RSP1/SP-substituted isocyanates, carbamic acid esters, thiocarbamic acid esters, carbamic acid halides or ureas on appropriately substituted benzenesulphonamides; or (3) by reacting RSP1/SP-substituted ureas, isourea or isothiourea ethers, or parabanic acids with appropriately substituted benzenesulphonyl halides and hydrolysing the products; or (4) by replacing the sulphur atom in appropriately substituted benzenesulphonyl-thioureas by an oxygen atom; or (5) by oxidizing appropriately substituted benzene-sulphinyl ureas or benzene-sulphenyl ureas; or (6) by acylating the corresponding #-aminoethyl compounds. Variations on the above methods are also referred to. N - {4 - [# - (2 - methoxy - 5 - methyl - benzamido) - ethyl] - benzenesulphonyl} - NSP1/SP - (2,5- endomethylenecyclohexylmethyl) - isourea - methyl ether is prepared by reacting the corresponding thiourea (prepared from 2,5-endomethylenecyclohexylmethylisothiocyanate and the appropriately substituted benzene sulphonamide) with methanol in presence of mercury oxide at 50-55‹ C. The corresponding isothiourea methyl ether is prepared from the same starting materials in the presence of methyl iodide at reflux. N - {4 - [# - (2 - methoxy - 5 - chlorobenzamido) - ethyl] - benzenesulphonyl} - NSP1/SP- (2,5 - endomethylene - cyclohexylmethyl) - thiourea is prepared as for the 5-methyl compound. N- {4 - [# - (2 - methoxy - 5 - chloro - benzamido)- ethyl] - benzenesulphonyl} - NSP1/SP - cyclohexyl - isothiourea methyl ether is prepared by reacting the appropriately substituted benzenesulphonamide with CS 2 and KOH in DMF and water to give the corresponding benzenesulphonyl iminodithio carbonic acid potassium salt, reacting this with dimethyl sulphate in the presence of NaOH to give the dimethyl ester of the free acid, and reacting this with cyclohexylamine. N- {4-[#- (2- methoxy - 5 - chlorobenzamido) - ethyl] - benzenesulphonyl} - 3 - cyclohexyl - parabanic acid is prepared from the corresponding benzenesulphochloride and 1-cyclohexyl-parabanic acid. N - {4 - [# - (2 - methoxy - benzamido) - ethyl]- benzenesulphonyl] - NSP1/SP - (4 - methylcyclohexyl)- urea is prepared by acylation of the corresponding #-aminoethyl compound with 2-methoxybenzoyl chloride; on bromination it gives the 5- bromo compound, a product of the invention. The benzenesulphonyl-ureas of the invention, which are stated to have a strong and longlasting hypoglycemic action, may be made up into pharmaceutical compositions for the treatment of diabetes mellitus with suitable carriers.
机译:1,153,272。苯磺酰脲。 FARBWERKE HOECHST A.G.,1966年7月25日[1965年7月27日],第33285/66号。标题C2C。该式的新化合物(其中R为C 1-4烷基或C 2-4烯基; X为卤素,C 1-4烷基或C 1-4烷氧基; R 1 为环己基, (1)通过胺NH 2 R 1 在适当取代的苯磺酰基异氰酸酯,苯磺酰基氨基甲酸酯的作用下制备甲基-或乙基-环己基或内亚甲基-(环己基或环己烯基)-甲基及其盐或硫代氨基甲酸酯,苯磺酰基氨基甲酸酯卤化物或苯磺酰基脲;或(2)通过R 1 取代的异氰酸酯,氨基甲酸酯,硫代氨基甲酸酯,氨基甲酸酯卤化物或脲在适当取代的苯磺酰胺上的作用;或(3)使R SP 1取代的脲,异脲或异硫脲醚或对羟基苯甲酸与适当取代的苯磺酰卤化物反应并水解产物;或(4)用氧原子代替适当取代的苯磺酰基-硫脲中的硫原子;或(5)通过氧化适当取代的苯-亚磺酰基脲或苯-亚磺酰基脲;或(6)通过酰化相应的#-氨基乙基化合物。还参考了上述方法的变型。制备N-{4--[#-​​(2-甲氧基-5-甲基-苯甲酰氨基)-乙基]-苯磺酰基}-N 1 -(2,5-内亚甲基环己基甲基)-异脲-甲醚通过使相应的硫脲(由2,5-内亚甲基环己基甲基异硫氰酸酯和适当取代的苯磺酰胺制备)与甲醇在氧化汞存在下于50-55°C反应。相应的异硫脲甲基醚由相同的原料在回流时的甲基碘。制备N-{4-[#-(2--甲氧基-5-氯苯甲酰胺基)-乙基]-苯磺酰基}-N 1 -(2,5--内亚甲基-环己基甲基)-硫脲5-甲基化合物。通过使适当取代的苯磺酰胺与适当的取代苯磺酰胺反应,制得N- {4--[#-​​(2--甲氧基-5-氯-苯甲酰胺基)-乙基]-苯磺酰基}-N 1 -环己基-异硫脲甲基醚在DMF和水中的CS 2和KOH生成相应的苯磺酰基亚氨基二硫代碳酸钾盐,在NaOH的存在下使其与硫酸二甲酯反应,得到游离酸的二甲基酯,并将其与环己胺反应。 N- {4-[#-(2-甲氧基-5-氯苯甲酰胺基)-乙基]-苯磺酰基} -3-环己基-对羟基苯甲酸是由相应的苯磺酰氯和1-环己基-对羟基苯甲酸制备的。通过将相应的#-氨基乙基化合物酰化来制备N-{4--[#-​​(2--甲氧基-苯甲酰氨基)-乙基]-苯磺酰基]-N 1 -(4-甲基环己基)-尿素用2-甲氧基苯甲酰氯;溴化后,得到本发明产物5-溴化合物。据说具有强而持久的降血糖作用的本发明的苯磺酰基-脲可以制成具有合适载体的用于治疗糖尿病的药物组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号